CMS on the sale of Radio-Onkologie Amsler AG

Bamcam Holding AG sold all shares in Radio-Onkologie Amsler AG to stock exchange listed Atrys Health Group.


The acquisition is part of Atrys Health’s long-term strategy to create a pan-European network of oncology clinics for high precision radiotherapy treatments and scale R&D for hypofractionated radiotherapy. Being the first acquisition of Atrys Health in Switzerland, it shall allow Atrys Health to enter a new market and add to its existing radiotherapy operations in Portugal and Spain.


A team from CMS Switzerland led by partner Stephan Werlen (pictured) and including Alexandra Stocker (associate, corporate / M&A) and Dr Simone Brauchbar Birkhäuser (counsel, IP / IT) advised BAMCAM Holding AG on all legal matters of the transaction.


Founded in 2003, radio-onkologie amsler ag today is one of the main providers of radiotherapy in the Basel area and operates two medical centers in Allschwil and Liestal.

Atrys Health is a Spanish biomedical company dedicated to providing diagnostic services and medical treatments primarily for oncology patients. Its activity mainly comprise diagnostic laboratory, telemedicine and radiotherapy.

CMS on the sale of Radio-Onkologie Amsler AG


Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2023 © All rights Reserved. Design by Origami Creative Studio


Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram